BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2225298)

  • 1. The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.
    Watson JT; Badner NH; Ali MJ
    Can J Anaesth; 1990 Oct; 37(7):798-800. PubMed ID: 2225298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management.
    Claure RE; Drover DD; Haddow GR; Esquivel CO; Angst MS
    Can J Anaesth; 2000 Apr; 47(4):334-7. PubMed ID: 10764178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
    Massimino K; Harrskog O; Pommier S; Pommier R
    J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of effective prophylaxis against intraoperative carcinoid crisis.
    Woltering EA; Wright AE; Stevens MA; Wang YZ; Boudreaux JP; Mamikunian G; Riopelle JM; Kaye AD
    J Clin Anesth; 2016 Aug; 32():189-93. PubMed ID: 27290972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity.
    Roy RC; Carter RF; Wright PD
    Anaesthesia; 1987 Jun; 42(6):627-32. PubMed ID: 2887127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uneventful spinal anesthesia for a patient with carcinoid syndrome managed with long-acting octreotide.
    Orbach-Zinger S; Lombroso R; Eidelman LA
    Can J Anaesth; 2002; 49(7):678-81. PubMed ID: 12193484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perianesthetic management of carcinoid syndrome: contribution of the bispectral EEG index].
    Capron F; Fialip S; Guitard I; Lasser P; Billard V
    Ann Fr Anesth Reanim; 2000 Aug; 19(7):552-5. PubMed ID: 10976372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment with somatostatin in the anaesthetic management of a patient with carcinoid syndrome.
    Parris WC; Oates JA; Kambam J; Shmerling R; Sawyers JF
    Can J Anaesth; 1988 Jul; 35(4):413-6. PubMed ID: 2900085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoid heart disease: a case report and literature review.
    Botero M; Fuchs R; Paulus DA; Lind DS
    J Clin Anesth; 2002 Feb; 14(1):57-63. PubMed ID: 11880025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist.
    Castillo JG; Filsoufi F; Adams DH; Raikhelkar J; Zaku B; Fischer GW
    Br J Anaesth; 2008 Nov; 101(5):618-26. PubMed ID: 18689806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Favorable outcome of a severe carcinoid cardiopathy after complete resection of the primary ovarian tumor].
    Kalinsky E; Cuillerier E; Lémann M; Rain JD; Ménasché S; Brenot F; Jian R
    Gastroenterol Clin Biol; 1998 Nov; 22(11):961-3. PubMed ID: 9881275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoid syndrome: the combined use of ketanserin and octreotide in the management of an acute crisis during anaesthesia.
    Hughes EW; Hodkinson BP
    Anaesth Intensive Care; 1989 Aug; 17(3):367-70. PubMed ID: 2774156
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraoperative Management of Carcinoid Heart Disease for Valvular Surgery.
    Dalal A; Stone M
    J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):1046-9. PubMed ID: 26776749
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
    Condron ME; Pommier SJ; Pommier RF
    Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of ovarian carcinoid causing heart failure.
    Mordi IR; Bridges A
    Scott Med J; 2011 Aug; 56(3):181. PubMed ID: 21873731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of right-sided heart failure symptoms after resection of a primary ovarian carcinoid tumor.
    Goldman T; Adamson K; Yang E
    Tex Heart Inst J; 2014 Oct; 41(5):533-6. PubMed ID: 25425990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary ovarian carcinoid heart disease curatively treated with a two-stage procedure.
    Bonaros N; Müller S; Bonatti J; Kafka R; Tzankov A; Bale R; Bartel T
    Thorac Cardiovasc Surg; 2007 Oct; 55(7):467-9. PubMed ID: 17902075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anesthetic Management of Gastrointestinal Carcinoid Tumors: A Case Report.
    Wiederholt B; Gengler T; Bendure J
    AANA J; 2022 Oct; 90(5):377-382. PubMed ID: 36173796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoid tumor and intravenous octreotide infusion during labor and delivery.
    Le BT; Bharadwaj S; Malinow AM
    Int J Obstet Anesth; 2009 Apr; 18(2):182-5. PubMed ID: 19200714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours.
    Kinney MA; Warner ME; Nagorney DM; Rubin J; Schroeder DR; Maxson PM; Warner MA
    Br J Anaesth; 2001 Sep; 87(3):447-52. PubMed ID: 11517130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.